Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept.

Chung HY, Kim DH, Lee EK, Chung KW, Chung S, Lee B, Seo AY, Chung JH, Jung YS, Im E, Lee J, Kim ND, Choi YJ, Im DS, Yu BP. · 2019

Read Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept. by Chung HY, Kim DH, Lee EK, Chung KW, Chung S, Lee B, Seo AY, Chung JH, Jung YS, Im E, Lee J, Kim ND, Choi YJ, Im DS, Yu BP. (2019) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc6457053.txt.

Introduction

Chung and co-authors propose senoinflammation as a fuller concept for the chronic, low-grade inflammation that accompanies aging and drives age-related disease. Two older ideas, molecular inflammation and inflammaging, each capture part of the picture but miss recent findings. The review assembles the newer network before naming the concept.

Aging switches on NF-κB signaling, cytokines, endoplasmic reticulum stress, inflammasomes, and lipid buildup, and senescent cells pour out a pro-inflammatory secretome that keeps the fire lit. MicroRNAs and toll-like receptors weave through the same web. Framing these as one process suggests anti-aging therapies should hit several pathways at once rather than chase single mediators.

Catalog record

CREATORChung HY, Kim DH, Lee EK, Chung KW, Chung S, Lee B, Seo AY, Chung JH, Jung YS, Im E, Lee J, Kim ND, Choi YJ, Im DS, Yu BP.
YEAR2019
COLLECTIONPAPERS
FORMATTXT
FILE SIZE77 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC6457053

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Redefining Chronic Inflammation in Aging and Age-Related Diseases: Proposal of the Senoinflammation Concept By Hae Young Chung, Dae Hyun Kim, Eun Kyeong Lee, Ki Wung Chung, Sangwoon Chung, Bonggi Lee, Arnold Y. Seo, Jae Heun Chung, Young Suk Jung, Eunok Im, Jaewon Lee, Nam Deuk Kim Published in: Aging and Disease DOI: 10.14336/AD.2018.0324 ABSTRACT Age-associated chronic inflammation is characterized by unresolved and uncontrolled inflammation with multivariable low-grade, chronic and systemic responses that exacerbate the aging process and age-related chronic diseases. Currently, there are two major hypotheses related to the involvement of chronic inflammation in the aging process: molecular inflammation of aging and inflammaging. However, neither of these hypotheses satisfactorily addresses age-related chronic inflammation, considering the recent advances that have been made in inflammation research. A more comprehensive view of age-related inflammation, that has a scope beyond the conventional view, is therefore required. In this review, we discuss newly emerging data on multi-phase inflammatory networks and proinflammatory pathways as they relate to aging. We describe the age-related upregulation of nuclear factor (NF)-κB signaling, cytokines/chemokines, endoplasmic reticulum (ER) stress, inflammasome, and lipid accumulation. The later sections of this review present our expanded view of age-related senescent inflammation, a process we term “senoinflammation”, that we propose here as a novel concept. As described in the discussion, senoinflammation provides a schema highlighting the important and ever-increasing roles of proinflammatory senescence-associated secretome, inflammasome, ER stress, TLRs, and microRNAs, which support the senoinflammation concept. It is hoped that this new concept of senoinflammation opens wider and deeper avenues for basic inflammation research and provides new insights into the anti-inflammatory therapeutic strategies targeting the multiple proinflammatory pathways and mediators and mediators that underlie the pathophysiological aging process. The inflammatory process is an essential immunological defense system in living organisms that has evolved to enhance species survival. Short-term, acute inflammation is a first-line defense mechanism that acts against harmful agents, such as pathogens, toxins, or allergens. Under normal conditions, the tightly coordinated actions of various defense components including immune cells, endogenous anti-inflammatory agents, and tissue remodeling processes enable the resolution of acute inflammation by facilitating the elimination of pathogens, infected cells, and repair to damaged tissues to restore body homeostasis [1]. However, when this intricate acute inflammatory response fails to resolve and persists, more defense components are mobilized to create a long-term unresolved immune response known as chronic inflammation. Chronic inflammation, which typically manifests itself in a low-grade manner for a prolonged period, involves macrophage- and lymphocyte-accumulated leukocytes [2], and various other cellular components. It is important to recognize that this chronic inflammation is causally associated with changes in the cellular redox state and cell death signaling pathways [3]. One of the major changes that occur during aging is the dysregulation of the immune response, leading to a chronic systemic inflammatory state. Among the dysregulated proinflammatory mediators, cytokines and chemokines are major culprits in the development of chronic inflammation and the immunosenescence process. For instance, interleukin (IL)-6, tumor necrosis factor (TNF)-α, and their receptors, are upregulated in aged tissues and cells [4]. Elevated levels of chemokines and C-reactive protein (CRP) have been found to be involved in age-related pathogenesis [5]. We have previously reported that several key intra- or inter-cellular signaling pathways are closely associated with age-related chronic inflammatory changes during aging [3,6-9]. In the aging literature, there are currently two major hypotheses related to age-related inflammation: inflammaging [10,11] and molecular inflammation [3,12-15]. These two are complementary to each other to a large extent but differ in their focus on age-related inflammatory phenomena. However, recent advances in the inflammation field have made it abundantly clear that age-related chronic inflammation needs to be comprehensively defined at the molecular, cellular, and systemic levels. Because chronic inflammation is so widely and deeply involved in many age-related chronic disorders such as atherosclerosis, diabetes, obesity, sarcopenia, and Alzheimer’s disease [15], it is necessary to establish a new pathophysiological basis for chronic inflammation in relation to the aging process. Figure 1.Schematic representation of the senoinflammation concept. MMP, matrix metalloproteinase; Infla-genes, proinflammatory genes; ER, endoplasmic reticulum; TLRs, Toll-like receptors; HMGB1, high-mobility group box 1; RAGE, receptor for advanced glycation end product. This review summarizes the current knowledge in the field of age-related inflammation. We further discuss the proinflammatory pathways involved in regulating the immunosenescence process and age-related chronic inflammation. We present a new concept with an expanded view of the overall picture of age-related chronic inflammation, which we call senescent inflammation (in short, “senoinflammation”). The salient feature of this concept is to incorporate many proinflammatory mechanisms that have not been previously considered to be important in age-related chronic inflammation. CURRENT UNDERSTANDING OF AGE-RELATED INFLAMMATORY PROCESSES Molecular level The nuclear factor (NF)-κB signaling pathway has been recognized as the most important key process underlying inflammation. Several studies, including ours, have reported that age-related NF-κB signaling upregulates the expression of the proinflammatory genes, TNF-α/β, ILs (IL-1β, IL-2, and IL-6), chemokines (IL-8; regulated on activation, normal T cell expressed and secreted [RANTES]), and adhesion molecules (AMs) [7-16], as shown in Figure 1. Furthermore, NF-κB-mediated upregulation of proinflammatory mediators such as CRP, IL-6, and TNF-α has been shown to be closely associated with various age-related chronic pathophysiological conditions [3]. The important role of NF-κB in maintaining immune responses during age-related inflammation involves activation of proinflammatory cells, leading to the increased expression of various cytokines and chemokines. Adler et al. [17] used motif mapping of the promoters of genes upregulated with aging and concluded that NF-κB is the transcriptional factor most closely associated with aging [17]. In addition, chronic activation of NF-κB has been detected in tissues including the skin, kidney, cardiac muscle, and brain (cerebellum and hypothalamus) [7,18-21]. Several aging studies on NF-κB, and its related signaling have provided important molecular insights into the altered cellular signaling systems that underlie chronic inflammation during aging. These signaling pathways include the insulin and insulin-like growth factor (IGF) pathways, 5'-AMP-activated protein kinase (AMPK)-mechanistic target of rapamycin (mTOR) pathway, Forkhead box O (FOXO) families, sirtuin (SIRT), and p53-related pathways [22]. Data from our laboratory have provided a molecular insight into how chronic stimulation of NF-κB activates inflammatory processes [23, 24]. Our studies have documented that age-associated NF-κB activation is exquisitely sensitive to redox state and oxidative stress, and subsequently leads to increased mitogen-activated protein kinase (MAPK)/inhibitor of NF-κB (IκB)-IκB kinase (IKK) signaling [25]. One interesting recent study has reported the activation of NF-κB occurs in the hypothalamus during aging [20]. The authors of this paper suggested that chronic activation of NF-κB signaling causes hypothalamic inflammation, which then affects whole-body metabolism, in particular, the endocrine regulation of glucose and lipid metabolism [20]. These findings render support for the possibility that dysregulated local tissue inflammation affects the systemic metabolic responses of the whole organism. These new revelations indicate that increased cellular inflammatory signaling pathways and tissue inflammation can propagate to systemic inflammation during the aging process. Cellular level The most noticeable cellular inflammatory changes in age-related chronic conditions are associated with macrophages. The well-known biological activities of macrophages include M1/M2 polarization, phagocytic activity, Toll-like receptor (TLR) signaling, and wound repair [26]. A decline in the expression of macrophage cell surface receptors, such as the major histocompatibility class (MHC)-II protein, has been reported in both aged

Read the complete text